XTX Topco’s UroGen Pharma URGN Stock Holding History

XTX Topco’s Portfolio URGN Stock Details URGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$713K	Buy	+19,386	New	+$525K	0.01%	2101
2026 Q1	–	Sell	-22,491	Closed	-$527K	–	4421
2025 Q4	$527K	Sell	22,491 -6,811	-23%	-$148K	0.01%	1546
2025 Q3	$585K	Buy	+29,302	New	+$526K	0.03%	957
2025 Q2	–	Sell	-25,967	Closed	-$287K	–	3209
2025 Q1	$287K	Buy	25,967 +7,326	+39%	+$78.1K	0.01%	1441
2024 Q4	$199K	Sell	18,641 -4,740	-20%	-$56.8K	0.02%	1564
2024 Q3	$297K	Buy	+23,381	New	+$347K	0.02%	1193
2023 Q3	–	Sell	-23,323	Closed	-$241K	–	2036
2023 Q2	$241K	Buy	+23,323	New	+$257K	0.04%	879
2022 Q4	–	Sell	-22,544	Closed	-$188K	–	1531
2022 Q3	$188K	Sell	22,544 -6,478	-22%	-$53.6K	0.05%	804
2022 Q2	$238K	Buy	+29,022	New	+$199K	0.1%	384

Other funds holding URGN

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

JFG

Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return

SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

ACA

Acorn Capital Advisors New York $366M AUM 474.6% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

XTX Topco's URGN Position: Q2 2026 in Review

XTX Topco opened a new position in UroGen Pharma (URGN) in Q2 2026: 19,386 shares worth $713K. The stake represents 0.01% of the portfolio and ranks #2101 among its holdings. This is a return to the name: XTX Topco previously reported a position in URGN as recently as Q4 2025.

XTX Topco first reported a position in URGN in Q2 2022 and has held it in 9 quarters since. 189 funds tracked by Wall St. Rank hold URGN as of Q2 2026.

XTX Topco held 19,386 shares of UroGen Pharma worth $713K as of Q2 2026.
UroGen Pharma was a new XTX Topco position in Q2 2026.
UroGen Pharma made up 0.01% of XTX Topco's portfolio in Q2 2026, its #2101 holding.
XTX Topco first reported a position in UroGen Pharma in Q2 2022 and has held it in 9 quarters since.
189 funds tracked by Wall St. Rank held UroGen Pharma as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.